Abstract
Latest advances in PET imaging, the growing importance of the theragnostic
approach and the inclusion of 18F-FDG in the staging guidelines of many oncological
situations put in shadow the research on SPECT radiopharmaceuticals, including those
considered classic as having oncological tropism. However, there are studies, some of
them very recent, that highlight an important role of MIBI in cancer imaging and
management. The dynamics of uptake and the wash-out process differ depending on
the cellular metabolism and can be used for various indications, one of them being
differentiation of malignant processes or predict chemotherapy resistance. In this paper,
we will review the literature and present most important actual and potential
application of 99m-Tc-MIBI scan in oncologic diseases.
Keywords: Chemoresistance, Malignancies, Metabolic Imaging, Nuclear Medicine, Oncology, Radiotracers, 99m-Tc-MIBI.
Related Journals
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents